Clinical Trials on Multiple Sclerosis, Relapsing-Remitting
Total 3124 results
-
Neuromed IRCCSUniversity of Rome Tor VergataNot yet recruitingHealthy | Neuromyelitis Optica | Relapsing-Remitting Multiple Sclerosis (RRMS)Italy
-
University Hospital, MontpellierCompletedProgressive Multiple Sclerosis | Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | ControlsFrance
-
University of South FloridaGenentech, Inc.Active, not recruitingPathologic Processes | Nervous System Diseases | Immune System Diseases | Multiple Sclerosis | Demyelinating Diseases | Autoimmune Diseases | Relapsing Remitting Multiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Boston Scientific CorporationTerminatedRelapsing Remitting Multiple SclerosisSpain, Germany, Belgium, Poland, France, Russian Federation
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Amanda IrishCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
Amphia HospitalSanofi; TEVA PharmachemieUnknown
-
Teva Branded Pharmaceutical Products R&D, Inc.Withdrawn
-
Réseau Sep Idf OuestCompletedFatigue | Relapsing Remitting Multiple Sclerosis | Cognitive TherapyFrance
-
Merck KGaA, Darmstadt, GermanyTerminatedMultiple Sclerosis, Relapsing-remittingGermany
-
Instituto Universitario de Oftalmobiología Aplicada...Hospital del Río Hortega; Fundación Eugenio Rodríguez PascualEnrolling by invitationProgressive Multiple Sclerosis | Multiple Sclerosis | Clinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisSpain
-
Merck KGaA, Darmstadt, GermanyMerck Quimica Argentina S.A.I.CCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
Terry L. WahlsActive, not recruitingClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
University of Alabama at BirminghamWashington University School of Medicine; United States Department of DefenseRecruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University Hospital, CaenActive, not recruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisFrance
-
Novartis PharmaceuticalsCompletedMultiple SclerosisItaly, Germany
-
BiogenTerminatedRelapsing Remitting Multiple SclerosisAustralia
-
Association de Recherche Bibliographique pour les...Centre Hospitalier Universitaire de Nice; Centre Hospitalier Princesse GraceCompletedHealthy | Clinically Isolated Syndrome | Multiple Sclerosis (MS) | Radiologically Isolated Syndrome | Multiple Sclerosis (MS) Relapsing Remitting | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary ProgressiveMonaco
-
University of VirginiaNational Multiple Sclerosis SocietyUnknownClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-remittingArgentina
-
University of Colorado, DenverCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
Instituto de Investigación Sanitaria de la Fundación...Universidad Rey Juan CarlosCompletedUrinary Incontinence | Relapsing-Remitting Multiple SclerosisSpain
-
University of Eastern FinlandCompletedQuality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple SclerosisFinland
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
Cantonal Hospital of St. GallenBiogenUnknownMultiple Sclerosis | Cognitive ImpairmentSwitzerland
-
University Hospital of Mont-GodinneUniversité Catholique de Louvain; Teva Pharmaceuticals USATerminatedRelapsing Remitting Multiple Sclerosis | Motor Deficits | Cognitive Deficits | Secondary-progressive Multiple SclerosisBelgium
-
University Hospital, BordeauxCompletedMultiple Sclerosis | Multiple Sclerosis, Acute RelapsingFrance
-
Centre Hospitalier Régional d'OrléansNational Scientific Research CentreCompletedMultiple Sclerosis | Multiple Sclerosis, Acute RelapsingFrance
-
Institut National de la Santé Et de la Recherche...BiogenUnknownNervous System Diseases | Progressive Multiple Sclerosis | Multiple Sclerosis | Eye Diseases | Optic Neuritis | Optic Nerve Diseases | Relapsing Remitting Multiple SclerosisFrance
-
University Hospital, CaenCompletedMultiple SclerosisFrance
-
University of Southern CaliforniaTeva Pharmaceuticals USACompletedRelapsing Remitting Multiple SclerosisUnited States
-
University of VermontCompletedFatigue | Sleep Initiation and Maintenance Disorders | Relapsing Remitting Multiple SclerosisUnited States
-
Clene NanomedicineClene Australia Pty LtdTerminatedRelapsing Remitting Multiple Sclerosis | Optic Neuropathy | Optic; Neuritis, With DemyelinationUnited States, Canada, Australia
-
Turku University HospitalCompletedMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingFinland
-
Artielle ImmunoTherapeuticsUnknownMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Johns Hopkins UniversityUnited States Department of DefenseCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Johns Hopkins UniversityCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Opexa Therapeutics, Inc.CompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Institut PasteurHöpital La Pitié-SalpêtrièreNot yet recruitingMultiple Sclerosis, Relapsing-RemittingFrance
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingSpain, Germany, Croatia, Turkey, Saudi Arabia, Hungary, Belgium, Australia, France, Portugal, Slovakia, United States, Bulgaria, Greece, Kuwait, Russian Federation, Tunisia, Italy, Argentina, Czechia, Israel, Serbia
-
University Hospital, Strasbourg, FranceBayer; Grünenthal GmbH; Fédération Hospitalo-Universitaire NEUROGENYCSRecruitingMultiple Sclerosis, Relapsing-RemittingFrance
-
Bosnalijek D.DMonitorCRORecruitingMultiple Sclerosis, Relapsing-RemittingTurkey
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
Washington University School of MedicineEMD SeronoActive, not recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Imcyse SAActive, not recruitingMultiple Sclerosis, Relapsing-RemittingMoldova, Republic of